INTRODUCTION
The search for new and effective drug delivery systems is a fundamental issue of continuous interest. CNTs (Carbon nano tubes) are unique, one-dimensional macromolecules. 1 SWCNTs (Single-walled carbon nano tubes) are constructed of a single sheet of graphite (diameter 0.4-2 nm), while MWCNTs (multi-walled carbon nano tubes) consist of multiple concentric graphite cylinders of increasing diameter of (2-100 nm). One of the major areas of CNTs research is the field of biomedical materials and devices. Many applications for CNTs have been proposed including biosensors, drug and vaccine delivery vehicles and novel biomaterials. 2 Nanotechnology has nearly limitless potential in biomedical applications. 3, 4 Nano particle, among all available drug carri- ers gain more attractive attention; since they can be so manipulated that remains in circulation system to reach the diseased site and can penetrate through the cell membrane. [3] [4] [5] Carbon nano tubes possess the capacity of penetrating the blood-brain barrier without causing the death of a living cell or without inflicting other damage. Carbon nano tubes, originally discovered by Iijima in 1991, are structures made up of thin sheets of benzene ring carbons rolled up into the shape of a seamless cylinder and are often capped on at least one end by a spherical bucky ball structure. 6, 7 In order to modify carbon nano tubes which increase their biocompatibility and solubility profile, different fictionalization approaches will apply to CNTs. 6 Therefore, fictionalization of carbon nano tubes is a key step for further their application. 7 The oxidative reactions are widely employed for chemical modification of CNTs which generate carboxylic groups to the tips and defect sites of CNTs. 8, 9 These functional groups can further attached to other reactive groups or biological molecules such as drugs and used to deliver their cargos to cells and organs.
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Experimental
Materials
The following chemicals were obtained from commercial suppliers and used as received: Nystatin 
Method
Oxidation of carbon nano tubes
MWCNTs expose to oxidative conditions, i.e. 150 mg of MWCNTs were treated with 3:1 mixture of concentrated sulphuric acid & nitric acid. This mixture was then sonicated (Ultrasonic Probe Sonicator, DP-120) simultaneously irradiated with varying amplitudes of ultrasonic energy up to 10 hrs. A probe has a tip diameter of 13 mm and is immersed 5 mm in the liquid. The device operates at a fixed wavelength of 20 kHz and is capable of inducing a maximum power output of 750 W. Upon completion, the mixture was washed with cold distilled water to remove the residual acid and then centrifuged at 3000 rpm, 4 o C (Cryocentrifuge 2810R, Eppendorf, USA) until the supernatant of the mixture represents the pH=7 which exhibit absence of acid residues in the suspension. Sample was then dried in vacuum (Krishna Technocreats, Basic) and kept in oven at 80°C for 4 hr.
Functionalization of carbon nano tubes with ethylene-diamine
150 mg of the oxidized nano tubes was dispersed by sonication in 75 mL of ethylenediamine. 7.5 mg of the EDAC was then added and sonicated (Ultrasonic Probe Sonicator, DP-120) for 4 h. The product was then diluted with excess methanol and centrifuged (Centrifuge Apparatus, RM-E2) to remove excess materials. The functionalized CNTs were then dried in a vacuum (Krishna Technocreats, Basic) oven at 80°C for 4 hr.
Two step conjugation process of Nystatin to carbon nano tubes a.
Step -I 10 ml of 250 µg ml -1 Nystatin solution was re-dispersed in 4 ml of 500 mM MES buffer solution followed by addition of 9.2 ml of 50 mg ml -1 NHS solution and mixed with fast stirring (Mechanical Stirrer, Omega Scientific Industries). Then add 4.8 ml of 10 mg ml -1 fresh EDAC aqueous solution quickly. Solution or mixture was continually stirred at room temperature for 30 min (Figure 1 ).
b. Step -II
Amide functionalized CNTs were re-dispersed in 90 ml of MES 50 mM buffer solution (pH=6.1) then above solution was added. After addition of above solution, nano tubes mixture was kept on platform shaker (Orbital Shaker, RIS-24BL) at 120 rpm at room temperature for 90 minutes. After shaking the mixture, the nano tubes suspension was then centrifuged (Centrifuge Apparatus, RM-E2) and wash with 50 mM MES buffer solution (pH = 6.1) three times to remove unbound Nystatin ( Figure 1 ).
Characterization of conjugated MWCNTs with Nystatin
Fourier-transform infrared (FTIR) Spectroscopy
IR spectra were measured with a Bruker Equinox 55S IR spectrometer, in the region of 400-4000 cm -1 with a resolution of 4 cm -1 , equipped with a DTGS detector. Each spectrum was the average of 200 scans collected at 2 cm -1 resolution.
UV-Vis Spectroscopy
The UV-Visible Spectrum of Pure Nystatin, f-MWCNTs, Nystatin conjugated to MWCNTs & unbound MWCNTs molecules were obtained in mixture of Glacial acetic acid & methanol (1:1 ratio). Samples were scanned over the range of 200-400 nm by using UV-Visible spectrophotometer (Jasco-1800).
Scanning Electron Microscopy (SEM)
Electron micrograph of Nystatin conjugated MWCNTs was obtained using a scanning electron microscope (JEOL JSM-5200) operating between 5 and 24 kV.
Transmission Electron Microscopy (TEM)
The size and morphology of the conjugated MWCNTs were characterized by a Philips CM-100 TEM equipped with Hamamatsu Digital Camera ORCA-HR operated using AMT software (Advanced Microscopy Techniques Corp, Danver, MA).
Ex-vivo Study: Minimum Inhibitory Concentration
Carbon nano tubes conjugated Nystatin was dissolved in dimethyl sulfoxide (DMSO)/absolute ethanol (at a ratio of 3:2), to an initial concentration of 10,000 μg/ml and stored at -20 o C until used. Bacterio static and bactericidal activities of nystatin towards Candida albicans, Candida parapsilosis and Candida neoformans were determined by the broth dilution technique as per McGinnis and Rinaldi (1996) . Briefly, 50 μl of the Carbon nano tubes conjugated Nystatin was two-fold serially diluted with Sabouraud-dextrose broth in a microtitre plate. An equal volume of yeast suspension (9×107 cells/ml) was added and mixed with the drug. DMSO/absolute ethanol (3:2 ratio) without nystatin was used as the control. The minimum inhibitory concentration (MIC) was determined visually following 24 h incubation at 37 o C for 2-3 days. The MIC was defined as the lowest concentration of the drug that inhibited growth of yeast cells, as indicated by the absence of turbidity (optically clear). Subculturing from the optically clear/turbid wells was performed to determine the minimum fungicidal concentration (MFC). The subcidal concentration of nystatin for all strains, used as positive control, in this study was the concentration slightly below the MFC of the drug. All experiments were repeated on two separate occasions, with duplicate determinations on each occasion.
RESULTS AND DISCUSSION
The IR spectrum of the pure MWCNTs (Figure 2A) showed the characteristic stretching vibrations of O-H groups at 3400 cm -1 . Peak at 1720 cm -1 appears in the spectrum of the oxidised MWCNTs ( Figure 2B ) is attributed to the C=O stretch of the carboxylic group (COOH) after the oxidation process on the surface of the oxidised MWCNTs. The FT/IR spectrum of a amide-functionalized MWCNTs ( Figure 2C We selected MWCNTs treated for 10 hr for further study as they exhibited the most convenient length & loading (Table 1) . From the antifungal activity (MIC and MFC) ( Table 2 and 3), amide f-MWCNTs, free of Nystatin, were inactive up to the maximal concentration (80 µg mL -1 ) used against all the microorganisms tested. Conversely, Conjugation of MWCNTs-Nystatin was highly effective; indicating that activity of the Nystatin was not prevented by its covalent bonding to CNTs. Amide f-CNTs (µg/ml) >80 >80 >80
MWCNTs-Nystatin (µg/ml) 6 4 2 
